The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
New ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management
Abstract
During the last 16 months, a Task Force established by the Guideline Committees of the European Society of Cardiology (ESC) and European Society of Anaesthesiology (ESA) has been working on a new Guideline document on cardiovascular assessment and management of patients undergoing non-cardiac surgery. The clinical scenario is common and the optimal management strategy for these patients is discussed by cardiologists, anaesthesiologists, surgeons, and other doctors and health personnel in our daily practice. The field is wide and complex, and is evolving with many new developments. The ESC decided in December 2012 to write a new Guideline on perioperative care, and established, together with the ESA, a new task force of experts co-chaired by Professor Steen D. Kristensen, Aarhus, Denmark (Figure 1) and Professor Juhani Knuuti, Turku, Finland (Figure 2). Professor Steen D. Kristensen. Professor Juhani Knuuti. The Guideline will cover the entire field including surgical risk assessment, pre-operative evaluation, and optimal perioperative management, and will also address relevant cardiological and anaesthesiological issues in patients with specific cardiac diseases and common co-morbidities scheduled to undergo non-cardiac surgery. The goal is to provide optimal guidance in the clinical decision-making process for patients undergoing non-cardiac surgery. Key areas with new recommendations based on scientific developments are: The use of perioperative beta-blocker treatment is complex, and has received a great deal of attention. As described in detail in a recent editorial by the Editor-in-chief of the European Heart Journal,1 the validity of some of the key publications in this field has been questioned, and burning issues on dosing, type of compound, and in particular which subgroups of patients that will benefit are difficult to resolve. Recent registry data show overall benefit of beta-blockers in some patients,2,3 but to address the use of beta-blockers properly, new randomized studies need to be conducted. Some colleagues and journalists have criticized the ESC and other leading scientific bodies for being too slow to react and change the Guidelines. However, as explained below, writing Guidelines is a lengthy process and includes the comprehensive study of the literature and evidence as well as a multistep review process—all of which are critical for the quality of the guidelines. Meanwhile, the ESC together with the American Heart Association (AHA) and the American College of Cardiology (ACC) decided in August 2013 to issue a common statement regarding temporary recommendations on the use beta-blockers: ‘In the interim, our current joint position is that the initiation of beta-blockers in patients who will undergo non cardiac surgery should not be considered routine, but should be considered carefully by each patient's treating physician on a case-by-case basis.’ In that statement, as well as earlier (March 2013), the ESC indicated that a new Guideline on non-cardiac surgery was in preparation. Our American colleagues from the AHA/ACC are also in the process of writing a new Guideline on this topic. How do we optimally evaluate pre- and perioperative risk and what kind of impact may it have on patients undergoing non cardiac surgery? New generation drug-eluting stents: should non-cardiac surgery be postponed and, if so, for how long? New and former antithrombotic drugs: what should we do if non-cardiac surgery is needed? When should we perform pre-operative revascularization? How do we handle patients with valve disease, arrhythmia, heart failure, and other cardiac diseases? What are the implications of co-morbidity such as diabetes, renal failure, and lung disease? What is the optimal perioperative medical treatment with, for example, beta-blockers, statins, angiotensin-converting enzyme (ACE) inhibitors/angiotensin receptor blockers (ARBs)? Guideline documents demand meticulous preparation, and their publication cannot be achieved in a rush for many reasons—the foremost being the safety of our patients. Once the development of an ESC Guideline is approved, the Committee for Practice Guidelines (CPG) chaired by Professor Zamorano from Madrid (Figure 3) prepares a list of potential authors to constitute the Task Force in charge of writing the Guideline. Among the Task Force members, one or two Task Force chairpersons are chosen. The list of potential members of the Task Force is prepared in collaboration with ESC constituent bodies concerned by the topic to be written. Eventually, 15–25 experts are nominated for each Guideline Task Force, which is under the co-ordination of the chairpersons. The Task Force, primarily, is responsible for the scientific content of the Guideline. Once they have produced a final draft document, it will be reviewed by CPG members and external reviewers appointed by the CPG in view of their knowledge in the field under discussion. Two members of the CPG co-ordinate the review
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
London, M. J., Hur, K., Schwartz, G. G., & Henderson, W. G. (2013) · JAMA · doi:10.1001/jama.2013.4135 · Cited by 219
Andersson, C., Mérie, C., Jørgensen, M. E., Gislason, G., Torp-Pedersen, C. T., Overgaard, C., Køber, L., Jensen, P. F., & Hlatky, M. A. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.11349 · Cited by 112
Cited by
Wanhainen, A., Verzini, F., Van Herzeele, I., Allaire, E., Bown, M., Cohnert, T., Dick, F., van Herwaarden, J., Karkos, C., Koelemay, M., et al. (2019) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2018.09.020 · Cited by 2,326
2024 ESC Guidelines for the management of peripheral arterial and aortic diseases
Mazzolai, L., Teixido-Tura, G., Lanzi, S., Boc, V., Bossone, E., Brodmann, M., Bura-Rivière, A., De Backer, J., Deglise, S., Della Corte, A., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae179 · Cited by 993
Naylor, R., Rantner, B., Ancetti, S., de Borst, G. J., De Carlo, M., Halliday, A., Kakkos, S. K., Markus, H. S., McCabe, D. J. H., Sillesen, H., et al. (2023) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2022.04.011 · Cited by 924
Editor's Choice – Management of the Diseases of Mesenteric Arteries and Veins
Björck, M., Koelemay, M., Acosta, S., Bastos Goncalves, F., Kölbel, T., Kolkman, J. J., Lees, T., Lefevre, J. H., Menyhei, G., Oderich, G., et al. (2017) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2017.01.010 · Cited by 658
Perioperative Management of Antithrombotic Therapy
Douketis, J. D., Spyropoulos, A. C., Murad, M. H., Arcelus, J. I., Dager, W. E., Dunn, A. S., Fargo, R. A., Levy, J. H., Samama, C. M., Shah, S. H., et al. (2022) · CHEST · doi:10.1016/j.chest.2022.07.025 · Cited by 450
Metadata
- Authors
- Kristensen, S. D., & Knuuti, J.
- Venue
- European Heart Journal
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-08-07
- Volume
- 35
- Issue
- 35
- Pages
- 2344-2345
- ISSN
- 0195-668X (ISSN-L)
- 1522-9645
- OpenAlex
- W2043200401
- Cited by
- 374
- References
- 2
- FWCI
- 19.16
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: New ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management. https://app.cochat.ai/papers/10.1093/eurheartj/ehu285
- The paper
- Kristensen, S. D., & Knuuti, J. (2014). New ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management. European Heart Journal. https://doi.org/10.1093/eurheartj/ehu285
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.